These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17229654

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase.
    Paydas S, Yavuz S, Disel U, Sahin B, Ergin M.
    Leuk Lymphoma; 2003 Dec; 44(12):2165-6. PubMed ID: 14959867
    [No Abstract] [Full Text] [Related]

  • 24. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy.
    Korte W, Jost C, Cogliatti S, Hess U, Cerny T.
    Ann Oncol; 1999 Oct; 10(10):1249-50. PubMed ID: 10586345
    [No Abstract] [Full Text] [Related]

  • 29. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
    Girard T, Nochy D, Montravers F, Der Sahakian G, Fior R, Galanaud P, Boué F.
    Leuk Lymphoma; 2004 Aug; 45(8):1703-5. PubMed ID: 15370230
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of B-cell lymphoma with a chimeric anti-CD20 monoclonal antibody(rituximab)].
    Tobinai K.
    Nihon Rinsho; 2002 Jan; 60(1):95-9. PubMed ID: 11808346
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.
    Rioufol C, Salles G.
    Expert Rev Anticancer Ther; 2015 May; 15(5):569-78. PubMed ID: 25818308
    [Abstract] [Full Text] [Related]

  • 34. Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia.
    Hagberg H, Lundholm L.
    Br J Haematol; 2001 Dec; 115(3):609-11. PubMed ID: 11736943
    [Abstract] [Full Text] [Related]

  • 35. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B, Demeter J, Eros N, Hársing J, Csomor J, Matolcsy A, Bottlik G, Gyori G, Marschalkó M, Kárpáti S.
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Rituximab immunotherapy for non-Hodgkin's lymphoma.
    White CA.
    Cancer Biother Radiopharm; 1999 Aug; 14(4):241-50. PubMed ID: 10850310
    [Abstract] [Full Text] [Related]

  • 38. Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier.
    Aide N, Irving L, Hicks RJ.
    Leuk Lymphoma; 2009 Jun; 50(6):865-7. PubMed ID: 19504393
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Rituximab not affected by statins?
    Pharmacogenomics; 2009 Feb; 10(2):259. PubMed ID: 19207027
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.